Holen Sie sich die Stockscreener-App
1.11
9.90%
0.10
Handel nachbörslich:
1.10
-0.01
-0.90%
Schlusskurs vom Vortag:
$1.01
Offen:
$1
24-Stunden-Volumen:
33.25M
Relative Volume:
1.40
Marktkapitalisierung:
$379.84M
Einnahmen:
$211.87M
Nettoeinkommen (Verlust:
$-551.61M
KGV:
-0.1627
EPS:
-6.8241
Netto-Cashflow:
$-140.45M
1W Leistung:
+3.74%
1M Leistung:
-18.98%
6M Leistung:
-38.33%
1J Leistung:
-71.24%
1-Tages-Spanne:
$0.996
$1.12
1-Wochen-Bereich:
$0.996
$1.12
52-Wochen-Spanne:
$0.77
$4.2472
Canopy Growth Corporation Stock (CGC) Company Profile
Firmenname
Canopy Growth Corporation
Sektor
Telefon
855-558-9333
Adresse
1 Hershey Drive, Smiths Falls, ON
Vergleichen Sie CGC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGC
Canopy Growth Corporation
|
1.11 | 345.62M | 211.87M | -551.61M | -140.45M | -6.8241 |
|
ZTS
Zoetis Inc
|
122.06 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.87 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.21 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.82 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Canopy Growth Corporation Stock (CGC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-10 | Hochstufung | The Benchmark Company | Sell → Hold |
| 2023-04-04 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-11-02 | Eingeleitet | Bernstein | Underperform |
| 2022-10-26 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2022-06-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-03-22 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2021-12-22 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-12-20 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-12-07 | Eingeleitet | Wells Fargo | Underweight |
| 2021-11-18 | Eingeleitet | Barclays | Equal Weight |
| 2021-11-08 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-11-08 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-11-08 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-10-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-08-12 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-06-02 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2021-05-25 | Hochstufung | MKM Partners | Neutral → Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-24 | Herabstufung | Jefferies | Hold → Underperform |
| 2021-02-10 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-02-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-02-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-04 | Hochstufung | CFRA | Buy → Strong Buy |
| 2020-06-01 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-06-01 | Herabstufung | Bryan Garnier | Neutral → Sell |
| 2020-06-01 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2020-06-01 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-01 | Herabstufung | Stifel | Buy → Sell |
| 2020-05-22 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-04-16 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-01-28 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2019-12-12 | Bestätigt | Cantor Fitzgerald | Neutral |
| 2019-11-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-15 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-14 | Herabstufung | Seaport Global Securities | Buy → Neutral |
| 2019-10-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2019-09-27 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-09-18 | Eingeleitet | Oppenheimer | Perform |
| 2019-08-26 | Hochstufung | Seaport Global Securities | Neutral → Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Canopy Growth Corporation Aktie (CGC) Neueste Nachrichten
Cannabis Stocks To Watch TodayNovember 17th - MarketBeat
Best Cannabis Stocks Worth WatchingNovember 18th - MarketBeat
Canopy Growth’s Remarkable Comeback: Should Investors Buy Now? - timothysykes.com
Top Cannabis Stocks Worth WatchingNovember 21st - MarketBeat
StockTalk | Cannabis Report: Growing the product reach | 2025-11-21 | Investing News - Stockhouse
(WEED) Investment Analysis and Advice (WEED:CA) - news.stocktradersdaily.com
How Canopy Growth Corporation (11L) stock gains from tech spendingJuly 2025 Review & Weekly Breakout Watchlists - newser.com
Cannabis Stocks To ConsiderNovember 20th - MarketBeat
Best Cannabis Stocks To Watch NowNovember 15th - MarketBeat
Price action breakdown for Canopy Growth CorporationJuly 2025 Outlook & Precise Trade Entry Recommendations - newser.com
Is Canopy Growth Corporation stock a safe haven assetWall Street Watch & Expert Curated Trade Ideas - newser.com
Canopy Growth No Longer A Strong Sell (NASDAQ:CGC) - Seeking Alpha
How high can Canopy Growth Corporation stock goWeekly Gains Report & High Accuracy Trade Signal Alerts - newser.com
Is Canopy Growth Corporation meeting your algorithmic filter criteriaMarket Trend Report & Growth-Oriented Investment Plans - newser.com
Why Canopy Growth Corporation (11L) stock is a must watch tickerWatch List & Daily Chart Pattern Signals - newser.com
Will Canopy Growth Corporation (11L) stock benefit from commodity supercycleJuly 2025 Rallies & Low Drawdown Momentum Ideas - newser.com
Why Canopy Growth Corporation stock could outperform in 2025July 2025 Action & Smart Allocation Stock Tips - newser.com
How Canopy Growth Corporation (11L) stock performs in volatility spikesAnalyst Upgrade & AI Based Buy and Sell Signals - newser.com
What makes Canopy Growth Corporation stock attractive to growth funds - newser.com
Volatility clustering patterns for Canopy Growth CorporationTrade Volume Summary & Daily Chart Pattern Signals - newser.com
What downside risks could hit Canopy Growth Corporation (11L) stockPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Measuring Canopy Growth Corporation’s beta against major indicesQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com
Is Canopy Growth Corporation stock attractive for retirement portfoliosJuly 2025 Action & Community Consensus Picks - newser.com
Growth Stocks To Keep An Eye OnNovember 17th - MarketBeat
Stocks in play: Canopy Growth Corporation - The Globe and Mail
Canopy Growth expands Australian medical cannabis product suite | 2025-11-18 | Investing News - Stockhouse
Canopy Growth Rolls Out New Medical Cannabis Softgels In Australia - Finimize
Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels - The Joplin Globe
Cannabis Stocks To Watch NowNovember 2nd - MarketBeat
Analyzing net buyer seller activity in Canopy Growth Corporation2025 Technical Patterns & Consistent Income Trade Recommendations - newser.com
Finanzdaten der Canopy Growth Corporation-Aktie (CGC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):